• ERT and Bioclinica are now Clario. Find out more about our new name, and why we have come together.

Your using an unsupported browser. Please update to a modern browser for a better experience.

Why centralize your ECGs

August 17, 2022

Webinar Session Information:

Cardiac safety issues are among the most common reasons for promising drugs being halted in development and not brought to market. Inaccurate cardiac safety data can put your patients — and trial — at unnecessary risk. Therefore, accurately identifying potential problems is crucial to keeping your trial on track. If you rely on site-managed ECGs, you may be risking data quality, which could extend study timelines, increase costs and, most importantly, place patients, trials and compounds at risk. Centralized ECG data collection delivers the highest quality data and keeps your trial on track.


Todd Rudo headshot

Todd Rudo, MD

VP, Cardiology and Deputy Chief Medical Officer at Clario

Dr. Todd Rudo is the Deputy Chief Medical Officer at Clario, with board certifications in cardiology, cardiac electrophysiology, nuclear cardiology, and adult echocardiography. He completed his general medical training at Jefferson Medical College in Philadelphia, PA, and specialty training at Lankenau Medical Center in Wynnewood, PA. After transitioning from private practice, Dr. Rudo has focused his career on drug safety / pharmacovigilance with responsibilities across multiple therapeutic areas within large and medium-size pharmaceutical companies. In his current role, he primarily supports cardiac safety consultative services, in addition to oversight of ECG core lab activities.

Kate Pristas

Sr Director, Product Management Cardiac at Clario

Kate Pristas is a Senior Director of Product Management at Clario. Kate has 18 years of experience at Clario including Operations, Validation, Project and Product Management. Currently, Kate oversees the Cardiac Safety Product Portfolio including product strategy, roadmap development and stakeholder management.